Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
5.00
-0.26 (-4.94%)
After-hours: Apr 28, 2026, 6:45 PM EDT
Journey Medical Revenue
In the year 2025, Journey Medical had annual revenue of $61.86M with 10.20% growth. Journey Medical had revenue of $16.08M in the quarter ending December 31, 2025, with 18.05% growth.
Revenue (ttm)
$61.86M
Revenue Growth
+10.20%
P/S Ratio
2.32
Revenue / Employee
$1,066,517
Employees
58
Market Cap
143.76M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 564.17M |
| Aurora Cannabis | 272.13M |
| Organigram Global | 204.21M |
| Lifecore Biomedical | 129.46M |
| Assertio Holdings | 118.71M |
| Anika Therapeutics | 112.82M |
| SIGA Technologies | 94.57M |
| Alpha Teknova | 40.52M |
DERM News
- 7 days ago - Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ - GlobeNewsWire
- 26 days ago - Journey Medical Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 4 weeks ago - Journey Medical Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 4 months ago - Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewsWire
- 5 months ago - Journey Medical Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire